Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Effectiveness of CoronaVac, ChAdOx1 nCoV-19, BNT162b2, and Ad26.COV2.S among individuals with previous SARS-CoV-2 infection in Brazil: a test-negative, case-control study
Thiago Cerqueira‐Silva, Jason R. Andrews, Viviane Boaventura, et al.
The Lancet Infectious Diseases (2022) Vol. 22, Iss. 6, pp. 791-801
Open Access | Times Cited: 120

Showing 51-75 of 120 citing articles:

Correlates of COVID-19 vaccine coverage in Arkansas: Results from a weighted random sample survey
Don E. Willis, Ramey Moore, Jennifer A. Andersen, et al.
Vaccine (2023) Vol. 41, Iss. 41, pp. 6120-6126
Open Access | Times Cited: 6
Hybrid immunity in immunocompromised patients with CLL after SARS-CoV-2 infection followed by booster mRNA vaccination
Lisa Blixt, Yu Gao, David Wullimann, et al.
Blood (2022) Vol. 140, Iss. 22, pp. 2403-2407
Open Access | Times Cited: 10
Effectiveness of Covid-19 vaccines (CovishieldTM and Covaxin ®) in healthcare workers in Mumbai, India: A retrospective cohort analysis
Aashish Contractor, Shashikala Shivaprakash, Anjali Tiwari, et al.
PLoS ONE (2022) Vol. 17, Iss. 10, pp. e0276759-e0276759
Open Access | Times Cited: 10
Omicron variants escape the persistent SARS-CoV-2-specific antibody response in 2-year COVID-19 convalescents regardless of vaccination
Miao Wang, Bing Zhou, Qing Fan, et al.
Emerging Microbes & Infections (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 10
Protection against COVID-19 hospitalisation conferred by primary-series vaccination with AZD1222 in non-boosted individuals: first vaccine effectiveness results of the European COVIDRIVE study and meta-regression analysis
Wilhelmine Meeraus, Leonie de Munter, Christen Gray, et al.
The Lancet Regional Health - Europe (2023) Vol. 31, pp. 100675-100675
Open Access | Times Cited: 5
Natural Antibodies Produced in Vaccinated Patients and COVID-19 Convalescents Recognize and Hydrolyze Oligopeptides Corresponding to the S-Protein of SARS-CoV-2
Anna M. Timofeeva, Sergey E. Sedykh, Tatyana A. Sedykh, et al.
Vaccines (2023) Vol. 11, Iss. 9, pp. 1494-1494
Open Access | Times Cited: 5
COVID-19 Booster Uptake: Are Hesitant Adopters Less Likely to Get a Booster Shot Than Nonhesitant Adopters?
Don E. Willis, Ramey Moore, James P. Selig, et al.
Behavioral Medicine (2023) Vol. 50, Iss. 3, pp. 260-268
Closed Access | Times Cited: 5
Understanding COVID-19 Vaccines Today: Are T-cells Key Players?
Areez Shafqat, Tarek Ziad Arabi, Belal Nedal Sabbah, et al.
Vaccines (2022) Vol. 10, Iss. 6, pp. 904-904
Open Access | Times Cited: 8
Short- and long-term noninvasive cardiopulmonary exercise assessment in previously hospitalised COVID-19 patients
Inderjit Singh, Phillip Joseph
European Respiratory Journal (2022) Vol. 61, Iss. 2, pp. 2201739-2201739
Open Access | Times Cited: 8
Complementarity determining regions in SARS-CoV-2 hybrid immunity
Glynis Frans, Doreen Dillaerts, Tom Dehaemers, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 4
COVID-19 inactivated and non-replicating viral vector vaccines induce regulatory training phenotype in human monocytes under epigenetic control
Mateus da Silva Matias Antunes, Fabrícia Heloisa Cavicchioli Sugiyama, Humberto Doriguêtto Gravina, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 4
Baseline immune states (BIS) associated with vaccine responsiveness and factors that shape the BIS
Djamel Nehar-Belaid, Mark Sokolowski, Sathyabaarathi Ravichandran, et al.
Seminars in Immunology (2023) Vol. 70, pp. 101842-101842
Open Access | Times Cited: 4
The Single-Dose Janssen Ad26.COV2.S COVID-19 Vaccine Elicited Robust and Persistent Anti-Spike IgG Antibody Responses in A 12-Month Ugandan Cohort
Jennifer Serwanga, Laban Kato, Violet Ankunda, et al.
(2024)
Open Access | Times Cited: 1
Booster Vaccination with BNT162b2 Improves Cellular and Humoral Immune Response in the Pediatric Population Immunized with CoronaVac
Diego A. Díaz-Dinamarca, Simone Cardenas-Cáceres, Nicolás A. Muena, et al.
(2024)
Open Access | Times Cited: 1
Imunização contra covid-19 e mortalidade em pacientes hospitalizados: coorte retrospectiva
Michelle Fernández, Alexandre Medeiros de Figueiredo, Adriano Massuda, et al.
Revista de Saúde Pública (2024) Vol. 58, Iss. 1, pp. 7-7
Open Access | Times Cited: 1
Modelling the impact of hybrid immunity on future COVID-19 epidemic waves
Thao P. Le, Isobel Abell, Eamon Conway, et al.
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Efficacy and Safety of an Inactivated Whole-Virion SARS-CoV-2 Vaccine (CoronaVac) in Brazilian Healthcare Professionals: The PROFISCOV Trial
José Moreira, Elizabeth González Patiño, Patrícia Emilia Braga, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Symptomatology and IgG Levels Before and After SARS-CoV-2 Omicron Breakthrough Infections in Vaccinated Individuals
Nigella M. Paula, Emerson Joucoski, Valter A. Baura, et al.
(2024)
Open Access | Times Cited: 1
Impact of COVID-19 Infection and Its Association With Previous Vaccination in Patients With Myasthenia Gravis in Korea: A Multicenter Retrospective Study
Hee Jo Han, Seung Woo Kim, Hyunjin Kim, et al.
Journal of Korean Medical Science (2024) Vol. 39, Iss. 18
Open Access | Times Cited: 1
Strong Neutralizing Antibody Responses to SARS-CoV-2 Variants Following a Single Vaccine Dose in Subjects With Previous SARS-CoV-2 Infection
Nina Ekström, Anu Haveri, Anna Solastie, et al.
Open Forum Infectious Diseases (2022) Vol. 9, Iss. 12
Open Access | Times Cited: 6
The Omicron variant wave: Where are we now and what are the prospects?
Mong‐Lien Wang, Lin Yang, Ju-Fen Hou, et al.
Journal of the Chinese Medical Association (2022) Vol. 86, Iss. 2, pp. 135-137
Open Access | Times Cited: 6
Impact of inactivated vaccines on decrease of viral RNA levels in individuals with the SARS-CoV-2 Omicron (BA.2) variant: A retrospective cohort study in Shanghai, China
Peng Yang, Bianli Dang, Wen Kang, et al.
Frontiers in Public Health (2023) Vol. 11
Open Access | Times Cited: 3
Modeling the impact of child vaccination (5–11 y) on overall COVID-19 related hospitalizations and mortality in a context of omicron variant predominance and different vaccination coverage paces in Brazil
Gabriel Cardozo Müller, Leonardo Souto Ferreira, Felipe Ernesto Mesias Campos, et al.
The Lancet Regional Health - Americas (2022) Vol. 17, pp. 100396-100396
Open Access | Times Cited: 5
Primary and booster vaccination in reducing severe clinical outcomes associated with Omicron Naïve infection
Chen-Yang Hsu, Jung‐Chen Chang, Sam Li-Shen Chen, et al.
Journal of Infection and Public Health (2022) Vol. 16, Iss. 1, pp. 55-63
Open Access | Times Cited: 4
[Chinese consensus on severe acute respiratory syndrome coronavirus-2 vaccination in adult patients with hematological diseases (2023)].

PubMed (2023) Vol. 44, Iss. 1, pp. 19-25
Closed Access | Times Cited: 2

Scroll to top